← Volver a los artículos

Transjugular Intrahepatic Portosystemic Shunt for the Management of Medically Refractory Chylous Ascites in Cirrhosis: A Single-Institution Retrospective Analysis

★ ★ ☆ ☆ ☆

Resumen del artículo

Título de Paperzilla
Milky Belly Be Gone! But Only 8 Patients Tried This Trick: A Tiny Study on Liver Shunts

This retrospective analysis of only eight patients explored the use of a transjugular intrahepatic portosystemic shunt (TIPS) to treat stubborn chylous ascites (milky fluid buildup) in individuals with cirrhosis who hadn't responded to other medical treatments. The study found that TIPS led to resolution of ascites in most patients (7 out of 8), with a mean transplant-free survival of 19 months, but also noted significant complications including a 25% incidence of hepatic encephalopathy and two patient deaths.

Explícamelo como si tuviera cinco años

Doctors tried a special procedure called TIPS on 8 people with liver disease whose bellies filled with milky fluid that wouldn't go away. For most, the fluid disappeared, but some had other problems like brain fog or even died, showing it's not a perfect fix.

Posibles conflictos de intereses

None identified

Limitaciones identificadas

Extremely Small Sample Size (N=8)
With only eight patients, the findings may not be generalizable to a larger population, and it's challenging to draw statistically robust conclusions about the efficacy and safety of TIPS for this condition.
Retrospective Design
As a retrospective study, it is susceptible to selection bias and information bias, as data was collected from existing records rather than through a controlled, pre-planned protocol, which can affect the reliability of the results.
Single-Institution Study
The results may be specific to the practices, patient demographics, and expertise of a single hospital, limiting their applicability and generalizability to other healthcare settings or diverse patient groups.
Lack of Long-Term Follow-Up
The paper itself acknowledges a lack of long-term follow-up, meaning the durability of the treatment's effects and the full spectrum of potential late complications are not adequately understood.
No Control Group
The study lacks a control group, making it impossible to compare the outcomes of TIPS against alternative treatments or standard medical management. Therefore, improvements cannot be definitively attributed solely to the TIPS procedure, nor can its comparative effectiveness be quantified.

Explicación de la calificación

This paper is a small, single-institution retrospective analysis with only eight patients, severely limiting the generalizability and strength of its findings. While it contributes to a sparsely researched area and describes a clinical experience, the design precludes strong conclusions about efficacy or safety. The significant adverse events (two deaths out of eight patients) also highlight potential risks not fully explored due to the study's design and size.

Conviene saber

Este es el análisis de Starter. Paperzilla Pro verifica cada cita, investiga los antecedentes de los autores y las fuentes de financiación, y utiliza razonamiento avanzado con IA para ofrecer información más exhaustiva.

Explorar Pro →

Jerarquía temática

Campo: Medicina
Subcampo: Hepatología

Información del archivo

Título original: Transjugular Intrahepatic Portosystemic Shunt for the Management of Medically Refractory Chylous Ascites in Cirrhosis: A Single-Institution Retrospective Analysis
Subido: 1 oct 2025, 5:06:30
Privacidad: Público